A group led by the Department of Neurosurgery, Brain Research Institute, Niigata University succeeded in the diagnosis of ...

Glioblastoma multiforme (GBM ... From the time of histologic diagnosis, the overall median survival time was 22.8 months. The authors conclude that the EGFRvIII mutation is a suitable immunogenic ...

Glioblastoma often kills within months ... One reason the disease is difficult to treat is, by the time it starts causing symptoms, the cancer is usually embedded in the brain by meandering ...